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background:  Ventricular arrhythmias are relatively common in ST-elevation myocardial infarction (STEMI). However, there are limited 
data on contemporary trends in the incidence of ventricular tachycardia (VT) and ventricular fibrillation (VF) in STEMI and association of VT 
and VF with outcomes in patients with STEMI.
methods:  We queried the 2003-2011 Nationwide Inpatient Sample databases to identify all patients aged > 20 years admitted with a 
primary diagnosis of STEMI. Patients with prior history of pacemaker implantation, implantable cardioverter defibrillator, cardiac arrest 
or non-ischemic cardiomyopathy were excluded. Temporal trends in the incidence of VT and VF were analyzed after adjusting for 
demographics, hospital characteristics and co-morbidities, using multivariate logistic regression. We also studied the association of VT and 
VF with outcomes in STEMI patients.
Results:  Of 2,077,629 patients hospitalized with STEMI, VT was documented in 167,241 (8.0%) patients and VF in 102,691 (4.9%) patients. 
The incidence of VT increased from 7.9% in 2003 to 8.7% in 2011 (Ptrend<0.001; adjusted OR 1.01; 95% CI 1.008-1.012), whereas the 
incidence of VF increased from 4.2% to 6.2% (Ptrend<0.001; adjusted OR 1.055; 95% CI 1.052-1.057). STEMI patients with VT had a higher 
risk-adjusted in-hospital mortality (14.3% vs 8.3%; adjusted OR 1.66, 95% CI 1.63-1.69, p<0.001), longer average length of stay (6 days vs 5 
days, P<0.001) and higher average total hospital charges ($85,539 vs $56,567, P<0.001) than those without VT. STEMI patients with VF had 
a higher risk-adjusted in-hospital mortality (24.9% vs 8.0%; adjusted OR 5.01, 95% CI 4.92-5.10, p<0.001), longer average length of stay (7 
days vs 5 days, P<0.001) and higher average total hospital charges ($94,411 vs $57,055, P<0.001) than patients without VF.
conclusion:  From 2003-2011, we observed a slight increase in incidence of VT and VF in STEMI patients. Both VT and VF were 
associated with higher in-hospital mortality, longer length of stay and higher average hospital cost in patients with STEMI.
